Given the relevant role of the body-mass index (BMI), obesity and diabetes as comorbidities in iGCA (Boeri et al., 2022), we also performed a literature search in order to determine MEG3 direction of expression in these circumstances. The gene discussed is MEG3; the disease is obesity disorder.